Activation of peripheral cannabinoid CB1 and CB2 receptors suppresses the maintenance of inflammatory nociception: a comparative analysis.
Br J Pharmacol. 2007 Jan;150(2):153-63. doi: 10.1038/sj.bjp.0706984. Epub 2006 Dec 11.
Br J Pharmacol. 2007.
PMID: 17160008
Free PMC article.